REDWOOD CITY, Calif., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel ...
TipRanks on MSN
Jasper Therapeutics reports data from ETESIAN Phase 1b study
Jasper Therapeutics (JSPR) reported positive preliminary clinical data from Jasper’s ETESIAN Phase 1b study of subcutaneous briquilimab in adult ...
REDWOOD CITY, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody ...
TipRanks on MSN
Jasper Therapeutics Reports Positive Phase 1b Study Results
Jasper Therapeutics ( ($JSPR) ) has provided an announcement. On December 2, 2025, Jasper Therapeutics announced positive preliminary clinical ...
REDWOOD CITY, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback